Scholars Central

OtherPublished 6 Jul 2016

International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks

Authors: Denis Lacombe, Anastassia Negrouk, John Bean

Clinical Investigation

Volume 1 · Issue 4 · Pages 493

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

International investigator-driven clinical trials (IDCTs) satisfy international standards for quality, achieve maximum efficiency, avoid duplication of effort, and realize effective and widespread implementation of research results into medical practice. This article focuses on specific intercontinental issues involving the development and conduct of IDCTs and reviews what is necessary for a successful international partnership, specifically, intergroup trials involving the European Organisation for Research and Treatment of Cancer (EORTC) and the US-based National Cancer Institute intergroup system. Through examples, it is shown that the lead group of an international intergroup IDCT must have the expertise and capabilities to work effectively in the international setting, establish working procedures, consider the regulatory environment and QA/QC in the trial setting, and secure the principles of academic independence.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Investigation
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Denis Lacombe”
  • BylineArticles whose byline prints “Anastassia Negrouk”
  • BylineArticles whose byline prints “John Bean”